Evidence map›Paper›PMID 41495039›Full record

ArticleNature communications2026

Filament assembly induced by the recognition of target DNA activates the prokaryotic Argonaute SPARDA system.

Wanyue Zhang, Yuchen Jiang, Yu Li, Xiangkai Zhen, Shuying Xu, Ning-Shao Xia, Shaowei Li, Xurong Wang, Qingbing Zheng, Songying Ouyang

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wanyue Zhang *Key Laboratory of Microbial Pathogenesis and Interventions of Fujian Province University Provincial University, the Key Laboratory of Innate Immune Biology of Fujian Province, Biomedical Research Center of South China, College of Life Sciences, Fujian Normal University, Fuzhou, 350117, China.
Yuchen Jiang *State Key laboratory of vaccines for infectious diseases, Xiang An Biomedicine laboratory, School of life Sciences, School of Public health, Xiamen University, Xiamen, China.
Yu Li *State Key laboratory of vaccines for infectious diseases, Xiang An Biomedicine laboratory, School of life Sciences, School of Public health, Xiamen University, Xiamen, China.ORCID http://orcid.org/0009-0008-5392-8917
Xiangkai Zhen *Key Laboratory of Microbial Pathogenesis and Interventions of Fujian Province University Provincial University, the Key Laboratory of Innate Immune Biology of Fujian Province, Biomedical Research Center of South China, College of Life Sciences, Fujian Normal University, Fuzhou, 350117, China.ORCID http://orcid.org/0000-0002-0767-7909
Shuying XuKey Laboratory of Microbial Pathogenesis and Interventions of Fujian Province University Provincial University, the Key Laboratory of Innate Immune Biology of Fujian Province, Biomedical Research Center of South China, College of Life Sciences, Fujian Normal University, Fuzhou, 350117, China.
Ning-Shao XiaState Key laboratory of vaccines for infectious diseases, Xiang An Biomedicine laboratory, School of life Sciences, School of Public health, Xiamen University, Xiamen, China.ORCID http://orcid.org/0000-0003-0179-5266
Shaowei LiState Key laboratory of vaccines for infectious diseases, Xiang An Biomedicine laboratory, School of life Sciences, School of Public health, Xiamen University, Xiamen, China. shaowei@xmu.edu.cn.ORCID http://orcid.org/0000-0002-3374-1038
Xurong WangKey Laboratory of Microbial Pathogenesis and Interventions of Fujian Province University Provincial University, the Key Laboratory of Innate Immune Biology of Fujian Province, Biomedical Research Center of South China, College of Life Sciences, Fujian Normal University, Fuzhou, 350117, China. William_wong@fjnu.edu.cn.
Qingbing ZhengState Key laboratory of vaccines for infectious diseases, Xiang An Biomedicine laboratory, School of life Sciences, School of Public health, Xiamen University, Xiamen, China. qbzheng@xmu.edu.cn.ORCID http://orcid.org/0000-0002-7516-9965
Songying OuyangKey Laboratory of Microbial Pathogenesis and Interventions of Fujian Province University Provincial University, the Key Laboratory of Innate Immune Biology of Fujian Province, Biomedical Research Center of South China, College of Life Sciences, Fujian Normal University, Fuzhou, 350117, China. ouyangsy@fjnu.edu.cn.ORCID http://orcid.org/0000-0002-1120-1524

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The short prokaryotic Argonaute (pAgo) proteins, in conjunction with their associated effector molecules, constitute a defence mechanism in prokaryotes that protects against phage infections. The SPARDA is characterized by its collateral nuclease activity, which, upon activation through target DNA recognition, non-specifically cleaves a wide range of nucleic acid substrates. Nevertheless, the structural underpinnings of its collateral activity have remained elusive. In this study, we investigate the NbaSPARDA system from Novosphingopyxis baekryungensis and reveal that RNA-guided DNA recognition triggers the assembly of a higher-order filamentous structure. This filamentation is essential for the tetramerization of the DREN nuclease domain, which in turn facilitates the accumulation and cleavage of substrate nucleic acids. Through the determination of the gRNA-bound and RNA-DNA duplex-bound cryo-EM structures, we delineate a sequential monomer-dimer-monomer-filament transition during SPARDA activation. These insights collectively elucidate a filament-dependent activation mechanism underpinning the short pAgo-mediated immune response, which is crucial for antiviral defence.

Indexed as

Argonaute ProteinsBacterial ProteinsDNACryoelectron MicroscopyModels, MolecularArgonaute ProteinsBacterial ProteinsDNA

Identifiers

PMID41495039
PMCPMC12774872

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.